Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000912057-02-037991
Filing Date
2002-10-08
Accepted
2002-10-08 15:03:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a2090825z424b3.htm 424B3 40656
3 G661987.JPG g661987.jpg GRAPHIC 4577
  Complete submission text file 0000912057-02-037991.txt   46903
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-86624 | Film No.: 02784083
SIC: 2835 In Vitro & In Vivo Diagnostic Substances